Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2014

Dec 29, 2014

30016_dirs_2014-12-29_93524f87-e1e0-45b1-8487-c567b300649a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-12-23

Reporting Person: MAZELSKY JAY (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-23 Common Stock M 1000 $95.06 Acquired 3366 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-23 Incentive Stock Option (right to buy) $95.06 M 1000 Disposed 2019-08-31 Common Stock (1000) Direct

Footnotes

F1: Grant of options to buy shares of common stock that became exercisable as to 51 shares on 09/01/2013 and 1,051 shares on 09/01/2014. The remaining options will become exercisable over the course of the next three grant date anniversaries on 09/01/2015, 09/01/2016 and 09/01/2017.